Home > Keywords >
| Catalog | name | Description | price |
|---|---|---|---|
| R-R-3045 | AZD4747 CAS No.2489226-14-2 | AZD4747/CAS No.2489226-14-2 is a selective, blood-brain barrier-permeable mutant GTPase KRASG12C inhibitor. AZD4747 has the potential to study cancer. | price> |
| R-C-1346 | 4E1Rcat CAS:328998-25-0 | 4E1RCat is an inhibitor of the eIF4F translation initiation complex that blocks eIF4E:eIF4G and eIF4E:4E-BP1 interactions.1 It has been shown to prevent the assembly of the eIF4F complex and to inhibit cap-dependent translation with an IC50 value of ~4 μM.1 4E1RCat was shown to reverse tumor chemoresistance in a mouse model of lymphoma by sensitizing cells to the proapoptotic action of DNA damage. | price> |
| R-R-3046 | K-Ras G12C-IN-3 CAS No.1629268-19-4 | K-Ras G12C-IN-3/CAS No.1629268-19-4 is a novel and irreversible inhibitor of mutant K-ras G12C. | price> |
| R-C-1347 | R-112 CAS: 575474-82-7 | R112 is a Syk inhibitor.R112 inhibited degranulation induced by anti-IgE cross-linking in mast cells(tryptase release,effective concentration for 50% inhibition[EC(50)]=353 nmol/L)or basophils(histamine release,EC(50)=280 nmol/L),and by allergen(dust mite)in basophils(histamine release,EC(50)=490 nmol/L). | price> |
| R-R-3047 | PROTAC KRAS G12C degrader-2 CAS No.2378257-72-6 | PROTAC KRAS G12C degrader-2 (compound 432)/CAS No.2378257-72-6 is a modulator of K-Ras protein hydrolysis. PROTAC KRAS G12C degrader-2 is a bifunctional compound, which contain on one end a cereblon inhibitor of apoptosis proteins (IAP) and on the other end a moiety which binds KRAS. | price> |
| R-C-1348 | WAY181187.HCl CAS:554403-08-6 | WAY-181187 is a potent and selective 5-HT6 receptor agonist.WAY-181187 possesses high affinity binding(2.2 and 4.8 nM,respectively)at the human 5-HT6 receptor and profile as full receptor agonists (WAY-181187:EC50=6.6 nM,Emax=93%). | price> |
| R-R-3048 | Spiclomazine CAS No.24527-27-3 | Spiclomazine (Clospirazine)/CAS No.24527-27-3 is a potent mutant KRAS(G12C) inhibitor that selectively inhibits mutant KRAS-driven pancreatic cancer. Spiclomazine can eliminate KRas-GTP levels in KRAS-driven pancreatic cancer and effectively inhibit RAS-mediated signaling. Spiclomazine significantly inhibits tumor progression in mouse renal capsule xenotransplantation models. | price> |
| R-C-1349 | fluoroclebopride CAS No. 154540-49-5 | Fluoroclebopride is a benzamide analog that is used in positron emission tomography(PET)applications.It binds reversibly to dopamine receptors(Kis= 0.95,5.7,5.46,and 144 nM for D2-like,D2(long),D3,and D4 receptors,respectively, in radioligand binding assays).It is selective for these receptors over D1, serotonin 5-HT2,and α2-adrenergic receptors(Kis=>10,000,283,and 1,300 nM, respectively). | price> |
| R-R-3049 | GDC-6036-NH CAS No.2417918-80-8 | GDC-6036-NH/CAS No.2417918-80-8 is from patent WO2020097537A2, and a precursor of compound 17 a/b. Compound 17 a/b is a RAS inhibitor and can be used in cancer research. | price> |
| R-C-1350 | BIBS39 CAS:133085-33-3 | BIBS 39 is a new nonpeptide angiotensin II(AII)receptor antagonist.Target: Angiotensin Receptorin vitro: BIBS 39 displaces[125I]AII from its specific binding sites with a Ki value of 29±7 nM for the AII subtype 1(AT1)receptor and a Ki value of 480±110 nM for the AII subtype 2(AT2)receptor.BIBS 222 shows a Ki value of 20±7 nM for the AT1 subtype and a Ki value of 730±170 nM for the AT2 subtype.BIBS 39 is 17 times more selective for the AT1 subtype and BIBS 222 37 times. | price> |
| R-R-3050 | K-Ras G12C-IN-1 CAS No.1629265-17-3 | K-Ras G12C-IN-1/CAS No.1629265-17-3 is a novel and irreversible inhibitor of mutant K-ras G12C extracted from patent WO 2014152588 A1. | price> |
| R-C-1351 | Alpelisib(BYL719) CAS:1217486-61-7 | Alpelisib(BYL-719)is a potent,selective, and orally active PI3Kα inhibitor. Alpelisib(BYL-719)shows efficacy in targeting PIK3CA-mutated cancer.Alpelisib (BYL-719)also inhibits p110α/p110γ/p110δ/p110β with IC50s of 5/250/290/1200 nM,respectively.Antineoplastic activity. | price> |
| R-R-3051 | KRASG12D-IN-1 | KRASG12D-IN-1 (compound 22) is a KRASG12D Inhibitor. KRASG12D-IN-1 has dose-dependent anti-tumor efficacy in the AsPC-1 xenograft mouse models with a tumor growth inhibition. | price> |
| R-C-1352 | THZ1 CAS:1604810-83-4 | THZ1 is a selective and potent covalent CDK7 inhibitor with an IC50 of 3.2 nM.THZ1 also inhibits the closely related kinases CDK12 and CDK13 and downregulates MYC expression. | price> |
| R-R-3052 | KRAS G12C inhibitor 28 CAS No.2649004-88-4 | KRAS G12C inhibitor 28/CAS No.2649004-88-4 is a KRAS G12C inhibitor with an IC50 of 57 nM. KRAS G12C inhibitor 28 has antitumor effects (WO2021113595A1; Example 1). | price> |
| R-C-1353 | Ezatiostat CAS:168682-53-9 | Ezatiosta(TER199,TLK199,Telintra),a tripeptide analog of glutathione,is a peptidomimetic inhibitor of Glutathione S-transferase P1-1(GSTP1-1).Ezatiostat activates c-Jun NH2 terminal kinase(JNK1)and ERK1/ERK2 and induces apoptosis. | price> |
| R-R-3053 | (R)-CE3F4 CAS No.1593478-56-8 | (R)-CE3F4/CAS No.1593478-56-8 is a potent and selective inhibitor of exchange protein directly activated by cAMP isoform 1 (Epac1), with an IC50 of 4.2 μM, with 10-fold selectivity for Epac1 over Epac2 (IC50, 44 μM). (R)-CE3F4 is more potent than racemic CE3F4 and (S)-CE3F4. | price> |
| R-C-1354 | Losartan Carboxylic Acid (EXP-3174) CAS:124750-92-1 | Losartan Carboxylic Acid(E-3174),an active carboxylic acid metabolite of Losartan, is an angiotensin II receptor type 1(AT1)antagonist.The Ki values are 0.97,0.57,0.67 nM for rat AT1B/AT1A and human AT1,respectively.Losartan Carboxylic Acid blocks the angiotensin II-induced responses in vascular smoothmuscle cells(VSMC).Losartan Carboxylic Acid elevates plasma renin activities and reduces mean arterial pressure. | price> |
| R-R-3054 | KRAS G12D inhibitor 1 CAS No.2621928-43-4 | KRAS G12D inhibitor 1 (example 243)/CAS No.2621928-43-4 is a KRAS G12D inhibitor, with an IC50 of 0.8 nM for KRAS G12D-mediated ERK phosphorylation. KRAS G12D inhibitor 1 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. | price> |
| R-C-1355 | MK7622 CAS:1227923-29-6 | MK-7622 is a muscarinic M1 receptor positive allosteric modulator.Target:M1 receptorMK-7622 is useful in the treatment of diseases in which the M1 receptor is involved,such as Alzheimer is disease,schizophreniapain or sleep disorders. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


